story of the week
Empagliflozin Slows Progression of Kidney Disease in Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
N. Engl. J. Med 2016 Jun 14;[EPub Ahead of Print], C Wanner, SE Inzucchi, JM Lachin, D Fitchett, M von Eynatten, M Mattheus, OE Johansen, HJ Woerle, UC Broedl, B ZinmanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.